Search results
Showing 946 to 960 of 1455 results for do not do recommendations
Recommendation ID NG131/4 Question What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate
Our experts can offer advice and support in contextualising our guidelines, or helping you adapt our content to your country or local context.
Recommendation ID NG126/01 Question Early pregnancy assessment units: A national evaluation of early pregnancy assessment unit service
Recommendation ID NG54/6 Question The experiences of people with learning disabilities and mental health problems in services:- What...
Recommendation ID IPG657/1 Question Current evidence on the safety of ultrasound-guided high‑intensity transcutaneous focused ultrasound
Vedolizumab for treating moderately to severely active ulcerative colitis (TA342)
Evidence-based recommendations on vedolizumab (Entyvio) for treating moderate to severe ulcerative colitis in adults.
Recommendation ID NG131/3 Question What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate
Recommendation ID NG131/5 Question What is the natural history of people with a Likert score on MRI of less than 3 without biopsy at...
Secukinumab for treating moderate to severe plaque psoriasis (TA350)
Evidence-based recommendations on secukinumab (Cosentyx) for treating plaque psoriasis in adults.
Recommendation ID IPG740/01 Question The evidence for treating an acute migraine attack is adequate but, for treating subsequent attacks
Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast. The tests are
Recommendation ID NG132/3 Question What are the long-term outcomes of different management strategies for primary hyperparathyroidism?
Evidence-based recommendations on trifluridine–tipiracil (Lonsurf) for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma in adults after 2 or more treatments.
Evidence-based recommendations on teduglutide (Resvestive) for treating short bowel syndrome in people 1 year and above.
Recommendation ID NG65/1 Question Referral criteria for people with suspected axial spondyloarthritis:- What are the optimal referral...